Autotransfusion Devices Market by Product and Geography - Forecast and Analysis 2020-2024

自己輸血デバイスの世界市場予測・分析:システム、アクセサリー

◆タイトル:Autotransfusion Devices Market by Product and Geography - Forecast and Analysis 2020-2024
◆商品コード:IRTNTR40094
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年11月
◆ページ数:151
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社の本調査レポートでは、自己輸血デバイスの世界市場について調べ、自己輸血デバイスの市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、自己輸血デバイスの市場規模をセグメンテーション別(製品別(システム、アクセサリー)、)と地域別(グローバル)に分けて算出しました。Technavio社は自己輸血デバイスの世界市場規模が2020-2024期間中に年平均6%成長すると予測しています。
・サマリー
・レポートの範囲
・自己輸血デバイスの市場状況
・自己輸血デバイスの市場規模
・自己輸血デバイスの市場予測
・自己輸血デバイスの世界環境:ファイブフォース分析
・市場セグメンテーション:製品別(システム、アクセサリー)
・自己輸血デバイスの顧客状況
・主要地域別市場規模:グローバル
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...

Global Autotransfusion Devices Market: About this market
Technavio’s autotransfusion devices market analysis considers sales from both systems and accessories products. Our study also finds the sales of autotransfusion devices in Asia, Europe, North America, and ROW. In 2019, the systems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing medical complications with allogeneic blood transfusion will play a significant role in the systems segment to maintain its market position. Also, our global autotransfusion devices market report looks at factors such as the rising number of cardiac and orthopedic surgeries, increasing demand for transplantation procedures, and complications related to allogeneic blood transfusion. However, high costs associated with autotransfusion, frequent product recalls, and limitations and presence of substitutes may hamper the growth of the autotransfusion devices industry over the forecast period.
Global Autotransfusion Devices Market: Overview
Rising number of surgeries
Blood transfusion is one of the key procedures to be performed during the intraoperative or postoperative procedures. Allogenic blood transfusion is mainly performed during the procedures, which may lead to various bacterial and viral infections. As a result, to avoid the risk of infection, autologous transfusions are being performed during these surgical procedures. Thus, an increase in various surgical procedures will lead to the expansion of the global autotransfusion devices market at a CAGR of almost 6% during the forecast period.
Technological advances
The procurement and maintenance of medical equipment account for a significant part of a healthcare organization’s operational expenses. However, the growing technological innovation has enabled a paradigm shift in cost as well as the manageability of medical equipment. For instance, the launch of wearable devices has made patient monitoring much simpler and cost-effective and contributes to higher patient adherence to health monitoring. Thus, all these factors have the potential to accelerate the growth of the global healthcare equipment market, including the global autotransfusion devices market. Moreover, several companies focus on the development of technological platforms that are integrated with autotransfusion systems to provide blood products to patients during surgical procedures This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global autotransfusion devices market during the forecast period 2020-2024, click here.
Competitive Landscape
With the presence of a few major players, the global autotransfusion devices market is concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading autotransfusion device manufacturers, that include Becton, Dickinson and Co., Brightwake Ltd., Fresenius Medical Care AG & Co. KGaA, Getinge AB, Haemonetics Corp., LivaNova Plc, Medtronic Plc, Redax Spa, Teleflex Inc., and Zimmer Biomet Holdings Inc.
Also, the autotransfusion devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Value chain analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Systems – Market size and forecast 2019-2024
• Accessories – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Business strategies
• Technological advances
• Growing awareness about risks related to allogeneic blood transfusion
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Becton, Dickinson, and Co.
• Brightwake Ltd.
• Fresenius Medical Care AG & Co. KGaA
• Getinge AB
• Haemonetics Corp.
• LivaNova Plc
• Medtronic Plc
• Redax Spa
• Teleflex Inc.
• Zimmer Biomet Holdings Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Product overview
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Systems – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Systems – Year-over-year growth 2020-2024 (%)
Exhibit 22: Accessories – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Accessories – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product recalls
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Business strategies and their market impact analysis
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Becton, Dickinson and Co. – Vendor overview
Exhibit 47: Becton, Dickinson and Co. – Business segments
Exhibit 48: Becton, Dickinson and Co. – Organizational developments
Exhibit 49: Becton, Dickinson and Co. – Geographic focus
Exhibit 50: Becton, Dickinson and Co. – Segment focus
Exhibit 51: Becton, Dickinson and Co. – Key offerings
Exhibit 52: Becton, Dickinson and Co. – Key customers
Exhibit 53: Brightwake Ltd. – Vendor overview
Exhibit 54: Brightwake Ltd. – Product segments
Exhibit 55: Brightwake Ltd. – Key offerings
Exhibit 56: Brightwake Ltd. – Key customers
Exhibit 57: Fresenius Medical Care AG & Co. KGaA – Vendor overview
Exhibit 58: Fresenius Medical Care AG & Co. KGaA – Business segments
Exhibit 59: Fresenius Medical Care AG & Co. KGaA – Organizational developments
Exhibit 60: Fresenius Medical Care AG & Co. KGaA – Geographic focus
Exhibit 61: Fresenius Medical Care AG & Co. KGaA – Segment focus
Exhibit 62: Fresenius Medical Care AG & Co. KGaA – Key offerings
Exhibit 63: Fresenius Medical Care AG & Co. KGaA – Key customers
Exhibit 64: Getinge AB – Vendor overview
Exhibit 65: Getinge AB – Business segments
Exhibit 66: Getinge AB – Organizational developments
Exhibit 67: Getinge AB – Geographic focus
Exhibit 68: Getinge AB – Segment focus
Exhibit 69: Getinge AB – Key offerings
Exhibit 70: Getinge AB – Key customers
Exhibit 71: Haemonetics Corp. – Vendor overview
Exhibit 72: Haemonetics Corp. – Business segments
Exhibit 73: Haemonetics Corp. – Organizational developments
Exhibit 74: Haemonetics Corp. – Geographic focus
Exhibit 75: Haemonetics Corp. – Segment focus
Exhibit 76: Haemonetics Corp. – Key offerings
Exhibit 77: Haemonetics Corp. – Key customers
Exhibit 78: LivaNova Plc – Vendor overview
Exhibit 79: LivaNova Plc – Business segments
Exhibit 80: LivaNova Plc – Organizational developments
Exhibit 81: LivaNova Plc – Geographic focus
Exhibit 82: LivaNova Plc – Segment focus
Exhibit 83: LivaNova Plc – Key offerings
Exhibit 84: LivaNova Plc – Key customers
Exhibit 85: Medtronic Plc – Vendor overview
Exhibit 86: Medtronic Plc – Business segments
Exhibit 87: Medtronic Plc – Organizational developments
Exhibit 88: Medtronic Plc – Geographic focus
Exhibit 89: Medtronic Plc – Segment focus
Exhibit 90: Medtronic Plc – Key offerings
Exhibit 91: Medtronic Plc – Key customers
Exhibit 92: Redax Spa – Vendor overview
Exhibit 93: Redax Spa – Product segments
Exhibit 94: Redax Spa – Key offerings
Exhibit 95: Redax Spa – Key customers
Exhibit 96: Teleflex Inc. – Vendor overview
Exhibit 97: Teleflex Inc. – Business segments
Exhibit 98: Teleflex Inc. – Organizational developments
Exhibit 99: Teleflex Inc. – Geographic focus
Exhibit 100: Teleflex Inc. – Segment focus
Exhibit 101: Teleflex Inc. – Key offerings
Exhibit 102: Teleflex Inc. – Key customers
Exhibit 103: Zimmer Biomet Holdings Inc. – Vendor overview
Exhibit 104: Zimmer Biomet Holdings Inc. – Product segments
Exhibit 105: Zimmer Biomet Holdings Inc. – Organizational developments
Exhibit 106: Zimmer Biomet Holdings Inc. – Geographic focus
Exhibit 107: Zimmer Biomet Holdings Inc. – Segment focus
Exhibit 108: Zimmer Biomet Holdings Inc. – Key offerings
Exhibit 109: Zimmer Biomet Holdings Inc. – Key customers
Exhibit 110: Validation techniques employed for market sizing
Exhibit 111: Definition of market positioning of vendors



【掲載企業】

Becton, Dickinson and Co., Brightwake Ltd., Fresenius Medical Care AG & Co. KGaA, Getinge AB, Haemonetics Corp., LivaNova Plc, Medtronic Plc, Redax Spa, Teleflex Inc., and Zimmer Biomet Holdings Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[自己輸血デバイスの世界市場予測・分析:システム、アクセサリー]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆